Profil
Jay R.
Campbell is currently a Director at Update Pharma, Inc. He previously worked as a Senior Development-Business Development at Kolltan Pharmaceuticals, Inc. and as a Chief Business Officer & VP-Investor Relations at Immutep Ltd. He completed his undergraduate degree at Bucknell University.
Postes actifs de Jay Campbell
| Sociétés | Poste | Début |
|---|---|---|
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Develops and provides anti-cancer drugs and other pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Jay Campbell
| Sociétés | Poste | Fin |
|---|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | Corporate Officer/Principal | - |
| IMMUTEP LIMITED | Investor Relations Contact | - |
Formation de Jay Campbell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | Health Technology |
Immutep Ltd.
Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
Bucknell University
Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Develops and provides anti-cancer drugs and other pharmaceutical products | Distribution Services |
















